Key facts
- Docline’s last known valuation is $3.8M (Aug 2019).
- It has raised $9.0M; the latest was Later Stage VC ($5.4M) in Oct 2025.
- Notable investors include 212Founders, Andalucia Open Future, EmergingTech Ventures, LionPride Investment, Odemira Capital — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Docline
- ·The full record, as it builds
Funding rounds
No funding rounds for Docline are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Docline
Developer of a telemedicine platform intended to provide digital health services to improve the healthcare industry. The company allows doctors to connect with their patients for video consultations, medical chat, electronic prescriptions, and manage appointments, and also connects with pharmacies to make the patient experience more valuable, enabling medical practitioners to provide personalized treatment.
- Sector
- Healthcare
- HQ
- Malaga, Spain
- Founded
- 2015
- Employees
- 45
- Website
- docline.com/
- Ownership
- Privately Held (backing)
Docline doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Docline shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Docline in its N-PORT filings yet. We sweep new filings monthly.